Integrated genomics identifies mi-32/MCL-1 pathway as a critical driver of melanomagenesis implications for mi-replacement and combination therapy

From WikiCitingRetracted

Jump to navigation Jump to search

Target Article[edit | edit source]

Integrated genomics identifies mi-32/MCL-1 pathway as a critical driver of melanomagenesis implications for mi-replacement and combination therapy; PJ Mishra, PJ Mishra, G Merlino; 2016; doi_citing_unknown

Retraction[edit | edit source]

Retracted article: Criteria-oriented psychological testing in the educational process: barriers and opportunities.; Knyazeva T.N. ; 2017-6-30

https://doi.org/10.15507/1991-9468.087.021.201702.345-1

Citation piece[edit | edit source]

Note: Open to append information.

Retrieved from "https://wikicitingretracted.org/index.php?title=Integrated_genomics_identifies_mi-32/MCL-1_pathway_as_a_critical_driver_of_melanomagenesis_implications_for_mi-replacement_and_combination_therapy&oldid=679"